+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Stem Cell Therapy Market by Type by Therapeutic Application, by Cell Source, and by End User: Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

  • ID: 4853086
  • Report
  • August 2018
  • Region: Global
  • 110 pages
  • Zion Market Research
1 of 2

Enquire about COVID-19 updates for this product.

Enquire Now

The report covers forecast and analysis for the stem cell therapy market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the stem cell therapy market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the stem cell therapy market on a global level.

In order to give the users of this report a comprehensive view of the stem cell therapy market, we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new service type launch, agreements, partnerships, collaborations & joint ventures, research & development, service type, and regional expansion of major participants involved in the market.

The study provides a decisive view of the stem cell therapy market by segmenting it on the basis of type, therapeutic area, cell source, end user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further categorization into major countries including the U.S., the UK, Germany, France, China, Japan, India, Brazil, etc. This segmentation includes demand for stem cell therapy market based on all segments in all the regions and countries.

The key players in the global stem cell therapy market are Anterogen Co., Ltd., RTI Surgical, Inc., Pharmicell Co., Ltd., MEDIPOST Co., Ltd., JCR Pharmaceuticals Co., Ltd., Holostem Terapie Avanzate S.r.l., NuVasive, Inc., and AlloSource.

This report segments the global stem cell therapy market as follows:

Global Stem Cell Therapy Market: Type Segment Analysis

  • Allogenic Stem Cells
  • Autologous Stem Cells

Global Stem Cell Therapy Market: Therapeutic Application Segment Analysis

  • Musculoskeletal Disorders
  • Wounds & Injuries
  • Cardiovascular Diseases
  • Gastrointestinal Diseases
  • Immune System Diseases
  • Other Applications

Global Stem Cell Therapy Market: Cell Source Segment Analysis

  • Adipose Tissue-Derived Mesenchymal SCs
  • Bone Marrow-Derived Mesenchymal SCs
  • Embryonic SCs
  • Other Sources

Global Stem Cell Therapy Market: End-User Segment Analysis

  • Hospital
  • Ambulatory Service Centers

Global Stem Cell Therapy Market: Regional Segment Analysis

  • North America
  • The U.S.
  • Europe
  • UK
  • France
  • Germany
  • Asia Pacific
  • China
  • Japan
  • India
  • Latin America
  • Brazil
  • The Middle East and Africa
Note: Product cover images may vary from those shown
2 of 2
  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global stem cell therapy market, 2015 - 2024 (USD Million)
    • 2.2. Global stem cell therapy market: Snapshot
  • Chapter 3. Stem Cell Therapy Market - Market Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global stem cell therapy market drivers: Impact analysis
      • 3.2.2. Increase in occurrence of chronic diseases
      • 3.2.3. Increase in support from government
    • 3.3. Market restraints
      • 3.3.1. Global stem cell therapy market restraints: Impact analysis
      • 3.3.2. High cost required for setup
    • 3.4. Opportunities
      • 3.4.1. Development of different technologies
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by type segment
      • 3.6.2. Market attractiveness analysis, by therapeutic application segment
      • 3.6.3. Market attractiveness analysis, by cell source segment
      • 3.6.4. Market attractiveness analysis, by end user segment
      • 3.6.5. Market attractiveness analysis, by regional segment
  • Chapter 4. Global Stem Cell Therapy Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global stem cell therapy market: company market share, 2017
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New material launch
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  • Chapter 5. Global Stem Cell Therapy Market -Type Segment Analysis
    • 5.1. Global stem cell therapy market: Type overview
      • 5.1.1. Global stem cell therapy market revenue share, by type, 2017 and 2024
    • 5.2. Allogenic stem cells
      • 5.2.1. Global stem cell therapy market for allogenic stem cells, 2015 - 2024 (USD Million)
    • 5.3. Autologous stem cells
      • 5.3.1. Global stem cell therapy market for autologous stem cells, 2015 - 2024 (USD Million)
  • Chapter 6. Global Stem Cell Therapy Market - Therapeutic Application Segment Analysis
    • 6.1. Global stem cell therapy market: Therapeutic Application overview
      • 6.1.1. Global stem cell therapy market revenue share, by therapeutic application, 2017 and 2024
    • 6.2. Musculoskeletal Disorders
      • 6.2.1. Global stem cell therapy market for musculoskeletal disorders, 2015 - 2024 (USD Million)
    • 6.3. Wounds & Injuries
      • 6.3.1. Global stem cell therapy market for wounds & injuries, 2015 - 2024 (USD Million)
    • 6.4. Cardiovascular Diseases
      • 6.4.1. Global stem cell therapy market for cardiovascular diseases, 2015 - 2024 (USD Million)
    • 6.5. Gastrointestinal Diseases
      • 6.5.1. Global stem cell therapy market for gastrointestinal diseases, 2015 - 2024 (USD Million)
    • 6.6. Immune System Diseases
      • 6.6.1. Global stem cell therapy market for immune system diseases, 2015 - 2024 (USD Million)
    • 6.7. Other Applications
      • 6.7.1. Glo`bal stem cell therapy market for other applications, 2015 - 2024 (USD Million)
  • Chapter 7. Global Stem Cell Therapy Market - Cell Source Segment Analysis
    • 7.1. Global stem cell therapy market: Cell Source overview
      • 7.1.1. Global stem cell therapy market revenue share, by cell source, 2017 and 2024
    • 7.2. Adipose Tissue-Derived Mesenchymal SCs
      • 7.2.1. Global stem cell therapy market for adipose tissue-derived mesenchymal SCs, 2015 - 2024 (USD Million)
    • 7.3. Bone Marrow Derived Mesenchymal SCs
      • 7.3.1. Global stem cell therapy market for bone marrow derived mesenchymal SCs, 2015 - 2024 (USD Million)
    • 7.4. Embryonic SCs
      • 7.4.1. Global stem cell therapy market for embryonic SCs, 2015 - 2024 (USD Million)
    • 7.5. Other Sources
      • 7.5.1. Global stem cell therapy market for other sources, 2015 - 2024 (USD Million)
  • Chapter 8. Global Stem Cell Therapy Market - End User Segment Analysis
    • 8.1. Global stem cell therapy market: sales channel overview
      • 8.1.1. Global stem cell therapy market revenue share, by end user, 2017 and 2024
    • 8.2. Hospital
      • 8.2.1. Global stem cell therapy market for hospital, 2015 - 2024 (USD Million)
    • 8.3. Ambulatory Service Centers
      • 8.3.1. Global stem cell therapy market for ASC, 2015 - 2024 (USD Million)
  • Chapter 9. Global Stem Cell Therapy Market - Regional Segment Analysis
    • 9.1. Global stem cell therapy market: Regional overview
      • 9.1.1. Global stem cell therapy market revenue share, by region, 2017 and 2024
    • 9.2. North America
      • 9.2.1. North America stem cell therapy market, 2015 - 2024 (USD Million)
      • 9.2.2. North America stem cell therapy market revenue, by type, 2015 - 2024 (USD Million)
      • 9.2.3. North America stem cell therapy market revenue, by therapeutic application, 2015 - 2024 (USD Million)
      • 9.2.4. North America stem cell therapy market revenue, by cell source, 2015 - 2024 (USD Million)
      • 9.2.5. North America stem cell therapy market revenue, by end user, 2015 - 2024 (USD Million)
      • 9.2.6. U.S.
        • 9.2.6.1. U.S. stem cell therapy market revenue, by type, 2015 - 2024 (USD Million)
        • 9.2.6.2. U.S. stem cell therapy market revenue, by therapeutic application, 2015 - 2024 (USD Million)
        • 9.2.6.3. U.S. stem cell therapy market revenue, by cell source, 2015 - 2024 (USD Million)
        • 9.2.6.4. U.S. stem cell therapy market revenue, by end user, 2015 - 2024 (USD Million)
      • 9.2.7. Canada
        • 9.2.7.1. Canada stem cell therapy market revenue, by type, 2015 - 2024 (USD Million)
        • 9.2.7.2. Canada stem cell therapy market revenue, by therapeutic application, 2015 - 2024 (USD Million)
        • 9.2.7.3. Canada stem cell therapy market revenue, by cell source, 2015 - 2024 (USD Million)
        • 9.2.7.4. Canada stem cell therapy market revenue, by end user, 2015 - 2024 (USD Million)
    • 9.3. Europe
      • 9.3.1. Europe stem cell therapy market, 2015 - 2024 (USD Million)
      • 9.3.2. Europe stem cell therapy market revenue, by type, 2015 - 2024 (USD Million)
      • 9.3.3. Europe stem cell therapy market revenue, by therapeutic application, 2015 - 2024 (USD Million)
      • 9.3.4. Europe stem cell therapy market revenue, by cell source, 2015 - 2024 (USD Million)
      • 9.3.5. Europe stem cell therapy market revenue, by end user, 2015 - 2024 (USD Million)
      • 9.3.6. UK
        • 9.3.6.1. UK stem cell therapy market revenue, by type, 2015 - 2024 (USD Million)
        • 9.3.6.2. UK stem cell therapy market revenue, by therapeutic application, 2015 - 2024 (USD Million)
        • 9.3.6.3. UK stem cell therapy market revenue, by cell source, 2015 - 2024 (USD Million)
        • 9.3.6.4. UK stem cell therapy market revenue, by end user, 2015 - 2024 (USD Million)
      • 9.3.7. Germany
        • 9.3.7.1. Germany stem cell therapy market revenue, by type, 2015 - 2024 (USD Million)
        • 9.3.7.2. Germany stem cell therapy market revenue, by therapeutic application, 2015 - 2024 (USD Million)
        • 9.3.7.3. Germany stem cell therapy market revenue, by cell source, 2015 - 2024 (USD Million)
        • 9.3.7.4. Germany stem cell therapy market revenue, by end user, 2015 - 2024 (USD Million)
      • 9.3.8. France
        • 9.3.8.1. France stem cell therapy market revenue, by type, 2015 - 2024 (USD Million)
        • 9.3.8.2. France stem cell therapy market revenue, by therapeutic application, 2015 - 2024 (USD Million)
        • 9.3.8.3. France stem cell therapy market revenue, by cell source, 2015 - 2024 (USD Million)
        • 9.3.8.4. France stem cell therapy market revenue, by end user, 2015 - 2024 (USD Million)
      • 9.3.9. Rest of Europe
        • 9.3.9.1. Rest of Europe stem cell therapy market revenue, by type, 2015 - 2024 (USD Million)
        • 9.3.9.2. Rest of Europe stem cell therapy market revenue, by therapeutic application, 2015 - 2024 (USD Million)
        • 9.3.9.3. Rest of Europe stem cell therapy market revenue, by cell source, 2015 - 2024 (USD Million)
        • 9.3.9.4. Rest of Europe stem cell therapy market revenue, by end user, 2015 - 2024 (USD Million)
    • 9.4. Asia Pacific
      • 9.4.1. Asia Pacific stem cell therapy market, 2015 - 2024 (USD Million)
      • 9.4.2. Asia Pacific stem cell therapy market revenue, by type, 2015 - 2024 (USD Million)
      • 9.4.3. Asia Pacific stem cell therapy market revenue, by therapeutic application, 2015 - 2024 (USD Million)
      • 9.4.4. Asia Pacific stem cell therapy market revenue, by cell source, 2015 - 2024 (USD Million)
      • 9.4.5. Asia Pacific stem cell therapy market revenue, by end user, 2015 - 2024 (USD Million)
      • 9.4.6. China
        • 9.4.6.1. China stem cell therapy market revenue, by type, 2015 - 2024 (USD Million)
        • 9.4.6.2. China stem cell therapy market revenue, by therapeutic application, 2015 - 2024 (USD Million)
        • 9.4.6.3. China stem cell therapy market revenue, by cell source, 2015 - 2024 (USD Million)
        • 9.4.6.4. China stem cell therapy market revenue, by end user, 2015 - 2024 (USD Million)
      • 9.4.7. Japan
        • 9.4.7.1. Japan stem cell therapy market revenue, by type, 2015 - 2024 (USD Million)
        • 9.4.7.2. Japan stem cell therapy market revenue, by therapeutic application, 2015 - 2024 (USD Million)
        • 9.4.7.3. Japan stem cell therapy market revenue, by cell source, 2015 - 2024 (USD Million)
        • 9.4.7.4. Japan stem cell therapy market revenue, by end user, 2015 - 2024 (USD Million)
      • 9.4.8. India
        • 9.4.8.1. India stem cell therapy market revenue, by type, 2015 - 2024 (USD Million)
        • 9.4.8.2. India stem cell therapy market revenue, by therapeutic application, 2015 - 2024 (USD Million)
        • 9.4.8.3. India stem cell therapy market revenue, by cell source, 2015 - 2024 (USD Million)
        • 9.4.8.4. India stem cell therapy market revenue, by end user, 2015 - 2024 (USD Million)
      • 9.4.9. Rest of Asia Pacific
        • 9.4.9.1. Rest of Asia Pacific stem cell therapy market revenue, by type, 2015 - 2024 (USD Million)
        • 9.4.9.2. Rest of Asia Pacific stem cell therapy market revenue, by therapeutic application, 2015 - 2024 (USD Million)
        • 9.4.9.3. Rest of Asia Pacific stem cell therapy market revenue, by cell source, 2015 - 2024 (USD Million)
        • 9.4.9.4. Rest of Asia Pacific stem cell therapy market revenue, by end user, 2015 - 2024 (USD Million)
    • 9.5. Latin America
      • 9.5.1. Latin America stem cell therapy market, 2015 - 2024 (USD Million)
      • 9.5.2. Latin America stem cell therapy market revenue, by type, 2015 - 2024 (USD Million)
      • 9.5.3. Latin America stem cell therapy market revenue, by therapeutic application, 2015 - 2024 (USD Million)
      • 9.5.4. Latin America stem cell therapy market revenue, by cell source, 2015 - 2024 (USD Million)
      • 9.5.5. Latin America stem cell therapy market revenue, by end user, 2015 - 2024 (USD Million)
      • 9.5.6. Brazil
        • 9.5.6.1. Brazil stem cell therapy market revenue, by type, 2015 - 2024 (USD Million)
        • 9.5.6.2. Brazil stem cell therapy market revenue, by therapeutic application, 2015 - 2024 (USD Million)
        • 9.5.6.3. Brazil stem cell therapy market revenue, by cell source, 2015 - 2024 (USD Million)
        • 9.5.6.4. Brazil stem cell therapy market revenue, by end user, 2015 - 2024 (USD Million)
      • 9.5.7. Rest of Latin America
        • 9.5.7.1. Rest of Latin America stem cell therapy market revenue, by type, 2015 - 2024 (USD Million)
        • 9.5.7.2. Rest of Latin America stem cell therapy market revenue, by therapeutic application, 2015 - 2024 (USD Million)
        • 9.5.7.3. Rest of Latin America stem cell therapy market revenue, by cell source, 2015 - 2024 (USD Million)
        • 9.5.7.4. Rest of Latin America stem cell therapy market revenue, by end user, 2015 - 2024 (USD Million)
    • 9.6. Middle East and Africa
      • 9.6.1. Middle East and Africa stem cell therapy market, 2015 - 2024 (USD Million)
      • 9.6.2. Middle East and Africa stem cell therapy market revenue, by type, 2015 - 2024 (USD Million)
      • 9.6.3. Middle East and Africa stem cell therapy market revenue, by therapeutic application, 2015 - 2024 (USD Million)
      • 9.6.4. Middle East and Africa stem cell therapy market revenue, by cell source, 2015 - 2024 (USD Million)
      • 9.6.5. Middle East and Africa stem cell therapy market revenue, by end user, 2015 - 2024 (USD Million)
  • Chapter 10. Company Profile
    • 10.1. Anterogen Co., Ltd.
      • 10.1.1. Overview
      • 10.1.2. Financials
      • 10.1.3. Product Portfolio
      • 10.1.4. Business Strategy
      • 10.1.5. Recent Developments
    • 10.2. RTI Surgical, Inc.
      • 10.2.1. Overview
      • 10.2.2. Financials
      • 10.2.3. Product Portfolio
      • 10.2.4. Business Strategy
      • 10.2.5. Recent Developments
    • 10.3. Pharmicell Co., Ltd.
      • 10.3.1. Overview
      • 10.3.2. Financials
      • 10.3.3. Product Portfolio
      • 10.3.4. Business Strategy
      • 10.3.5. Recent Developments
    • 10.4. MEDIPOST Co. ., Ltd.
      • 10.4.1. Overview
      • 10.4.2. Financials
      • 10.4.3. Product Portfolio
      • 10.4.4. Business Strategy
      • 10.4.5. Recent Developments
    • 10.5. JCR Pharmaceuticals Co., Ltd.
      • 10.5.1. Overview
      • 10.5.2. Financials
      • 10.5.3. Product Portfolio
      • 10.5.4. Business Strategy
      • 10.5.5. Recent Developments
    • 10.6. Holostem Terapie Avanzate S.r.l.
      • 10.6.1. Overview
      • 10.6.2. Financials
      • 10.6.3. Product Portfolio
      • 10.6.4. Business Strategy
      • 10.6.5. Recent Developments
    • 10.7. NuVasive, Inc.
      • 10.7.1. Overview
      • 10.7.2. Financials
      • 10.7.3. Product Portfolio
      • 10.7.4. Business Strategy
      • 10.7.5. Recent Developments
    • 10.8. AlloSource
      • 10.8.1. Overview
      • 10.8.2. Financials
      • 10.8.3. Product Portfolio
      • 10.8.4. Business Strategy
      • 10.8.5. Recent Developments
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll